HighGravityData
Companies / Humana / Filing

Humana — Nov 5, 2025 release

Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-25-000055
Open on SEC.gov ↗
Showing in the filing
Diluted earnings per share (EPS) - GAAP
“approximately $12.26”
Period
FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 25
GAAP EPS for FY2025
“approximately $12.26”
Insurance segment benefit ratio for FY2025
“90.1 percent to 90.5 percent”
Individual Medicare Advantage membership (de… for FY2025
“approximately 425,000 members”
Adjusted FY 2025 EPS for FY2025
“approximately $17.00”
Diluted earnings per share (EPS) - Adjusted … for FY2025
“approximately $17.00”
Diluted EPS - Non-GAAP for FY2025
“approximately $17.00”
Diluted EPS - GAAP for FY2025
“approximately $12.26”
Diluted earnings per share (EPS) - GAAP for FY2025
“approximately $12.26”
Total Revenues Consolidated - GAAP for FY2025
“at least $128 billion”
Total Revenues Insurance segment - GAAP for FY2025
“at least $123 billion”
Total Revenues CenterWell segment - GAAP for FY2025
“at least $21.5 billion”
Change in year-end medical membership - Indi… for FY2025
“Decline of approximately 425,000”
Change in year-end medical membership - Grou… for FY2025
“Relatively flat”
Change in year-end medical membership - Medi… for FY2025
“Growth of approximately 200,000”
Change in year-end medical membership - Stat… for FY2025
“Growth of approximately 160,000”
Operating Cost Ratio - Consolidated GAAP for FY2025
“11.6% to 12.1%”
Operating Cost Ratio - Consolidated Non-GAAP for FY2025
“11.3% to 11.7%”
Insurance segment income from operations - G… for FY2025
“$1.6 billion to $2.0 billion”
CenterWell segment income from operations - … for FY2025
“$1.1 billion to $1.5 billion”
CenterWell segment income from operations - … for FY2025
“$1.3 billion to $1.7 billion”
Effective Tax Rate - GAAP for FY2025
“approximately 20.0%”
Effective Tax Rate - Non-GAAP for FY2025
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2025
“approximately 121 million”
Cash flows from operations - GAAP for FY2025
“$2.4 billion to $2.9 billion”
Capital expenditures for FY2025
“approximately $650 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Learn more about what we offer at Humana.com and at CenterWell.com. 13 Humana Inc. Full Year 2025 Projections - As of November 5, 2025 Diluted earnings per common share (EPS) As of 3Q25 Earnings As of 2Q25 Earnings GAAP: approximately $12.26 GAAP: approximately $13.77 no change Non-GAAP: approximately $17.00 Total Revenues Consolidated no change GAAP: at least $128 billion Consolidated and segment level revenue projections include expected investment income. Segment level revenues include amounts that eliminate in consolidation. Insurance segment no change GAAP: at least $123 billion CenterWell segment no change GAAP: at least $21.5 billion Change in year-end medical membership from prior year-end Individual Medicare Advantage Decline of approximately 425,000 Decline of 'up to 500,000' Group Medicare Advantage no change Relatively flat Medicare stand-alone PDP no change Growth of approximately 200,000 State-based contracts Growth of approximately 160,000 Growth within 175,000 to 250,000 range State-based contracts guidance includes membership in Florida, Illinois, Indiana, Kentucky, Louisiana, Ohio, Oklahoma, South Carolina, Virginia, and Wisconsin. Benefit Ratio  Insurance segment no change GAAP: 90.1% to 90.5% Ratio calculation: benefits expense as a percent of premiums revenues. Operating Cost Ratio Consolidated GAAP: 11.6% to 12.1% Non-GAAP: 11.3% to 11.7% GAAP: 11.3% to 11.7% Ratio calculation: operating costs ex
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.